skynesher/E+ via Getty Images Psyence Biomedical ( NASDAQ: PBM ) said Wednesday it received a letter from Nasdaq for not meeting the minimum bid price of $1.00 per share required for continued listing. Psyence Biomedical ( PBM ) has 180 calendar days, or until December 24, 2024 to regain compliance with the Minimum Bid Price Rule.
Source: Press Release More on Psyence Biomedical Ltd. Financial information for Psyence Biomedical Ltd..